-
Value proposition
Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain. The company is leveraging advances brain delivery technology to enable targeted delivery of next-generation RNAi therapeutics to the CNS. Aerska is headquartered in Dublin, Ireland, with research operations in Stevenage, UK.
-
Aerska | RNA medicines for diseases of the brain
Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
https://www.aerska.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Sofinnova Partners
Financial Services (Auto) |
Sofinnova Partners
Financial Services (Auto) |
Other
3 Sep 2026 |
|
|
Entrepreneurs First
Startup accelerator & VC, Venture Capital and Private Equity Principals (Auto) |
Entrepreneurs First
Startup accelerator & VC, Venture Capital and Private Equity Principals (Auto) |
Other
16 Feb 2026 |
|
|